Application of In-vitro Bioassay for 137Cs During the Emergency Phase of the Goiania Accident

Abstract

In the Goiania accident, many individuals suffered external and internal contamination. The screening of internal contamination was done through 137Cs urinary excretion. During the first month after the accident, only in-vitro bioassay procedures were done. Incorporation into the body and committed doses were estimated using age-specific mathematical models correlating these quantities to the 137Cs excreted in urine. The ratio of feces to urine of 137Cs excretion was used to evaluate the effectiveness of the administration of Prussian Blue on removal of 137Cs from the body.